Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 31Carcinoma, Non-Small-Cell Lung 4Urinary Bladder Neoplasms 3Neoplasm Metastasis 3Colorectal Neoplasms 3Brain Neoplasms 3Stomach Neoplasms 2Salivary Gland Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Multiple Myeloma 2Lymphoma 2Lung Neoplasms 2Hematologic Neoplasms 2Wilms Tumor 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Pleuropulmonary blastoma 1Pathologic Complete Response 1Neurofibrosarcoma 1Neuroblastoma 1

Interventions

trastuzumab biosimilar HLX02 1pertuzumab 1Trastuzumab 1Taxes 1Surgical Procedures, Operative 1Radiotherapy 1Radiation 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Mastectomy, Segmental 1Mastectomy 1Magnetic Resonance Spectroscopy 1Fluorodeoxyglucose F18 1Drug Therapy 1Docetaxel 1Albumin-Bound Paclitaxel 1Ado-Trastuzumab Emtansine 12C4 antibody 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anatomic Stage II Breast Cancer AJCC v8 × Ado-Trastuzumab Emtansine × Clear all
NCT04266249 2026-05-05

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
2,175 enrolled
Breast

Anatomic Stage II Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡